Phreesia Says Its Contract With The CMS Innovation Center For Use Of The Patient Activation Measure Has Been Renewed Through 2029
Portfolio Pulse from Benzinga Newsdesk
Phreesia has announced the renewal of its contract with the CMS Innovation Center for the use of the Patient Activation Measure, extending the agreement through 2029.
October 01, 2024 | 10:53 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Phreesia's contract renewal with the CMS Innovation Center for the Patient Activation Measure through 2029 is a positive development, indicating sustained collaboration and potential revenue stability.
The renewal of the contract with a significant entity like the CMS Innovation Center suggests ongoing business and potential revenue stability for Phreesia. This is likely to be viewed positively by investors, as it indicates a stable relationship and continued use of Phreesia's services.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90